Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. (2018)
Attributed to:
Integrating innovative technologies for genotyping and phenotyping in stratified medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s11306-018-1367-3
PubMed Identifier: 29805336
Publication URI: http://europepmc.org/abstract/MED/29805336
Type: Journal Article/Review
Volume: 14
Parent Publication: Metabolomics : Official journal of the Metabolomic Society
Issue: 6
ISSN: 1573-3882